Premium
Moderna Inc (MRNA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -3.65 | -10.7733175915 | 33.88 | 35.48 | 30.1 | 8655005 | 31.89130256 | CS |
| 4 | -6.42 | -17.517053206 | 36.65 | 37.92 | 29.25 | 12232496 | 33.3310471 | CS |
| 12 | -15.23 | -33.5019797624 | 45.46 | 48.92 | 29.25 | 11188364 | 37.34982519 | CS |
| 26 | -42.17 | -58.2458563536 | 72.4 | 79.9587 | 29.25 | 8928677 | 44.12306024 | CS |
| 52 | -64.42 | -68.0612783941 | 94.65 | 170.47 | 29.25 | 6399710 | 66.25337913 | CS |
| 156 | -110.59 | -78.5328788524 | 140.82 | 217.25 | 29.25 | 5271878 | 108.15304057 | CS |
| 260 | 2.24 | 8.00285816363 | 27.99 | 497.17 | 19.31 | 9392116 | 145.04423998 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
